Scoopfeeds — Intelligent news, curated.
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?
business

Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?

Yahoo Finance · May 26, 2026, 12:09 PM · Also reported by 3 other sources

Key takeaways

  • Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?
  • (NYSE:ZBH) also received a rating update from Citizens on April 29.
  • (NYSE:ZBH) designs, manufactures, and markets orthopedic reconstructive products.

Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy? Noor Ul Ain Rehman Tue, May 26, 2026 at 7:09 PM GMT+7 2 min read ZBH Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, and as it relates to its US go-to-market transformation, the company called out modest disruption in Q1 within expectations as it continued to execute the changes. This occurred with specialization increasing to ~30% of the force, non-dedicated reps declining to below 60%, and early productivity gains in transitioned territories.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) also received a rating update from Citizens on April 29. The firm cut the price target on the stock to $105 from $120, maintaining an Outperform rating on the shares. The firm stated that the company delivered stronger EPS outperformance in fiscal Q1 and a modest revenue beat, which was largely driven by tariff-related benefits boosting margins. It further told investors in a research note that although core performance was mixed, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) raised its EPS guidance and maintained its revenue outlook to reflect tariff impacts. According to Citizens, 2026 is still viewed as a transitional year.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) designs, manufactures, and markets orthopedic reconstructive products. It also offers biologics, extremities, sports medicine, dental implants, trauma products, and related surgical products. The company operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific.

Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop